Unknown

Dataset Information

0

Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.


ABSTRACT: Background: Cholera is an acute voluminous dehydrating diarrheal disease caused by toxigenic strains of Vibrio cholerae O1 and occasionally O139. A growing body of evidence indicates that immune responses targeting the O-specific polysaccharide (OSP) of V. cholerae are involved in mediating protection against cholera. We therefore assessed whether antibody responses against OSP occur after vaccination with live attenuated oral cholera vaccine CVD 103-HgR, and whether such responses correlate with protection against cholera.

Methodology: We assessed adult North American volunteers (n = 46) who were vaccinated with 5 × 108 colony-forming units (CFU) of oral cholera vaccine CVD 103-HgR and then orally challenged with approximately 1 × 105 CFU of wild-type V. cholerae O1 El Tor Inaba strain N16961, either 10 or 90 days post-vaccination.

Principal findings: Vaccination was associated with induction of significant serum IgM and IgA anti-OSP and vibriocidal antibody responses within 10 days of vaccination. There was significant correlation between anti-OSP and vibriocidal antibody responses. IgM and IgA anti-OSP responses on day 10 following vaccination were associated with lower post-challenge stool volume (r = -0.44, P = 0.002; r = -0.36, P = 0.01; respectively), and none of 27 vaccinees who developed a ?1.5 fold increase in any antibody isotype targeting OSP on day 10 following vaccination compared to baseline developed moderate or severe cholera following experimental challenge, while 5 of 19 who did not develop such anti-OSP responses did (P = 0.01).

Conclusion: Oral vaccination with live attenuated cholera vaccine CVD 103-HgR induces antibodies that target V. cholerae OSP, and these anti-OSP responses correlate with protection against diarrhea following experimental challenge with V. cholerae O1.

Trial registration: ClinicalTrials.gov NCT01895855.

SUBMITTER: Islam K 

PROVIDER: S-EPMC5906022 | biostudies-literature | 2018 Apr

REPOSITORIES: biostudies-literature

altmetric image

Publications

Anti-O-specific polysaccharide (OSP) immune responses following vaccination with oral cholera vaccine CVD 103-HgR correlate with protection against cholera after infection with wild-type Vibrio cholerae O1 El Tor Inaba in North American volunteers.

Islam Kamrul K   Hossain Motaher M   Kelly Meagan M   Mayo Smith Leslie M LM   Charles Richelle C RC   Bhuiyan Taufiqur Rahman TR   Kováč Pavol P   Xu Peng P   LaRocque Regina C RC   Calderwood Stephen B SB   Simon Jakub K JK   Chen Wilbur H WH   Haney Douglas D   Lock Michael M   Lyon Caroline E CE   Kirkpatrick Beth D BD   Cohen Mitchell M   Levine Myron M MM   Gurwith Marc M   Harris Jason B JB   Qadri Firdausi F   Ryan Edward T ET  

PLoS neglected tropical diseases 20180406 4


<h4>Background</h4>Cholera is an acute voluminous dehydrating diarrheal disease caused by toxigenic strains of Vibrio cholerae O1 and occasionally O139. A growing body of evidence indicates that immune responses targeting the O-specific polysaccharide (OSP) of V. cholerae are involved in mediating protection against cholera. We therefore assessed whether antibody responses against OSP occur after vaccination with live attenuated oral cholera vaccine CVD 103-HgR, and whether such responses correl  ...[more]

Similar Datasets

| S-EPMC4872293 | biostudies-literature
| S-EPMC1594734 | biostudies-literature
| S-EPMC5834340 | biostudies-literature
| S-EPMC5477385 | biostudies-literature
| S-EPMC1698305 | biostudies-literature
| S-EPMC7214932 | biostudies-literature
| S-EPMC5088018 | biostudies-literature
| S-EPMC6863522 | biostudies-literature
| S-EPMC2600311 | biostudies-literature
| S-EPMC4102861 | biostudies-literature